"Do agents that block the RAS truly offer renoprotective effects in early stage, nonproteinuric nephropathy?" by Radica Alicic

Selected Works of Katherine R. Tuttle, MD, FASN, FACP, FNKF

Follow Contact

Article

Do agents that block the RAS truly offer renoprotective effects in early stage, nonproteinuric nephropathy?

Current Hypertension Reports (2007)

Radica Alicic, University of Washington
Katherine R. Tuttle, University of Washington

Link

Disciplines

Medicine and Health Sciences,
Endocrinology, Diabetes, and Metabolism,
Endocrinology and
Internal Medicine

Publication Date

January 10, 2007

DOI

10.1007/s11906-007-0073-8

Citation Information

Radica Alicic and Katherine R. Tuttle. "Do agents that block the RAS truly offer renoprotective effects in early stage, nonproteinuric nephropathy?" Current Hypertension Reports Vol. 9 Iss. 5 (2007) p. 393 - 402
Available at: http://works.bepress.com/katherine-tuttle/111/